Clinical Trials Directory

Trials / Completed

CompletedNCT03174691

Early Luteal Progesterone Profile in IVF Patients Triggered With hCG

The Early Luteal Progesterone Profile in IVF Patients Triggered With hCG

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
161 (actual)
Sponsor
Vietnam National University · Academic / Other
Sex
Female
Age
18 Years – 42 Years
Healthy volunteers
Not accepted

Summary

Until now very little information exists regarding the early luteal serum progesterone profile after Human chorionic gonadotropin (hCG) trigger. This pilot study will help characterize the serum progesterone, 17-hydroxyprogesterone profiles in IVF patients and correlate progesterone, 17-Hydroxyprogesterone levels to ovarian follicles obtained after stimulation with exogenous gonadotropins.

Detailed description

The early luteal phase after IVF treatment is only scarcely studied. During IVF treatment the early luteinizing hormone (LH) activity deficit induced after ovarian stimulation with exogenous gonadotropins will be partly covered by the bolus of hCG used for triggering of final oocyte maturation due to the long half-life of hCG. In addition, the luteal phase will be covered by exogenous progesterone supplementation. After successful implantation the embryo itself will provide the supportive LH activity, securing the function of the corpora lutea. However, during the early luteal phase and peri-implantation, recent data suggest that an early-mid-luteal hCG/LH deficiency exists after hCG trigger during which the corpus luteum lacks an optimal stimulation. Furthermore, the early luteal progesterone profile in IVF differs significantly from the progesterone profile of the natural cycle, in which the peak is reached around the time of implantation. With this non-invasive trial, we wish to further explore the early luteal phase profiles of progesterone, 17-Hydroxyprogesterone and hCG in order to optimize current luteal phase support policies in IVF and hopefully increase ongoing pregnancy rates.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTBlood collectionA total of ten (10) blood samples (2ml/each) will be collected during the study. Blood samples will be collected on the following days for subsequent analysis of LH, Estradiol, hCG, progesterone and 17-Hydroxyprogesterone.

Timeline

Start date
2017-06-07
Primary completion
2017-08-08
Completion
2017-08-08
First posted
2017-06-02
Last updated
2019-08-06

Locations

1 site across 1 country: Vietnam

Source: ClinicalTrials.gov record NCT03174691. Inclusion in this directory is not an endorsement.